Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis

Project Information

iCHEMGENODRUGS_TB

Grant agreement ID: 795924

DOI

10.3030/795924

Project closed

EC signature date 28 March 2018

Start date 1 September 2018

End date 31 August 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 148 635,60

EU contribution

€ 148 635,60

Coordinated by

UNIVERSIDADE NOVA DE LISBOA
Portugal

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs

Author(s): Liliana Rodrigues, Pedro Cravo, Miguel Viveiros
Published in: Expert Review of Anti-infective Therapy, Issue 18/8, 2020, Page(s) 741-757, ISSN 1478-7210
Publisher: Future Drugs Ltd.
DOI: 10.1080/14787210.2020.1760845